Max Portfolio Pct.
Check
Valuation
Check
Stock Quality:
Max Portfolio Pct.
Check
Valuation
Check
GMED Price Action
Last 7 days
-3.1%
Last 30 days
2.9%
Last 90 days
14.6%
Trailing 12 Months
-17.9%
GMED RSI Chart
GMED Valuation
GMED Price/Sales (Trailing)
The Good, Bad and Ugly
Growth
Profitability
Size
Dilution Risk
Balance Sheet
Momentum
Funds Popularity
Insider Trading
GMED Fundamentals
GMED Revenue
GMED Earnings
GMED Profitability
GMED Investor Care
Revenue & Growth
Historical Charts for Stock Metrics
Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2025 | 2.5B | 2.6B | 0 | 0 |
| 2024 | 1.9B | 2.2B | 2.5B | 2.5B |
| 2023 | 1.1B | 1.1B | 1.2B | 1.6B |
| 2022 | 961.3M | 973.9M | 998.4M | 1.0B |
| 2021 | 825.8M | 927.9M | 941.5M | 958.1M |
| 2020 | 793.0M | 747.4M | 767.3M | 789.0M |
| 2019 | 721.5M | 742.7M | 769.6M | 785.4M |
| 2018 | 654.6M | 675.6M | 693.1M | 713.0M |
| 2017 | 580.5M | 595.4M | 611.5M | 636.0M |
| 2016 | 552.4M | 556.3M | 555.0M | 564.0M |
| 2015 | 491.8M | 511.8M | 531.0M | 544.8M |
| 2014 | 443.7M | 450.2M | 460.8M | 474.4M |
| 2013 | 396.3M | 407.3M | 419.8M | 434.5M |
| 2012 | 347.9M | 363.0M | 373.5M | 386.0M |
| 2011 | 299.0M | 309.8M | 320.7M | 331.5M |
| 2010 | 0 | 0 | 0 | 288.2M |
Get all data in R, Python etc through our Historical Stock Data APIs
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales presence, as well as its hip and knee products primarily through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
| CEO | Mr. Daniel T. Scavilla |
|---|---|
| WEBSITE | globusmedical.com |
| SECTOR | Healthcare |
| INDUSTRY | Medical Devices |
| EMPLOYEES | 2600 |
